Scott Goldman

Scott Goldmank

Symphony Health

Scott Goldman

Scott has spent his career successfully driving change and innovation in the pharmaceutical, biotechnology, and life sciences industries. His leadership has unlocked value at both small start-up enterprises and large companies with revenues in excess of $20 billion. As a management consultant at PricewaterhouseCoopers (PwC) and other respected firms, Scott uncovered insights that led to the achievement of organizational KPIs, as well as successful technological change. Scott contributed to health industry thought leadership as part of PwC’s Health Research Institute team. Prior to his consulting career, Scott held key strategy, sales, marketing and operation roles in the pharmaceutical and life science industry. At Eli Lilly, he developed national account marketing investment strategies, and delivered rapid sales increases in the areas under his supervision. At Janssen Pharmaceuticals, Scott made investment recommendations to senior management that substantially increased unit operational efficiency and effectiveness. Scott holds a Bachelor of Science in Applied Sciences in Engineering from Rutgers University, and a MBA from Goizueta Business School at Emory University.